1.
Mancino P, Falasca K, Ucciferri C, Pizzigallo E, Vecchiet J. USE OF HEMATOPOIETIC GROWTH FACTOR IN THE MANAGEMENT OF HEMATOLOGICAL SIDE EFFECTS ASSOCIATED TO ANTIVIRAL TREATMENT FOR HCV HEPATITIS. Mediterr J Hematol Infect Dis [Internet]. 2010Mar.26 [cited 2020Mar.29];2(1):e2010003. Available from: http://www.mjhid.org/index.php/mjhid/article/view/2010.003